Cuffe Michael S. 4
4 · HCA Healthcare, Inc. · Filed Sep 12, 2024
Insider Transaction Report
Form 4
Cuffe Michael S.
EVP and Chief Clinical Officer
Transactions
- Exercise/Conversion
Common Stock
2024-09-10$145.24/sh+22,080$3,206,899→ 51,758.209 total - Sale
Common Stock
2024-09-12$385.42/sh−8,358$3,221,340→ 29,678.209 total - Exercise/Conversion
Stock Appreciation Right
2024-09-10−22,080→ 0 totalExercise: $145.24Exp: 2030-01-29→ Common Stock (22,080 underlying) - Tax Payment
Common Stock
2024-09-10$386.43/sh−13,722$5,302,592→ 38,036.209 total
Footnotes (3)
- [F1]The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2024.
- [F2]Includes 2,518.2085 shares acquired under the Issuer's employee stock purchase plans.
- [F3]The stock appreciation rights vested in four equal annual installments beginning on January 29, 2021.